Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: ADAPTIVE BIOTECHNOLOGIES CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-02-28 to 2026-02-27
Current total value of award: $44850
Description: CLONOSEQ HAS RECEIVED CLEARANCE FROM THE FOOD AND DRUG ADMINISTRATION FOR AN IN VITRO DIAGNOSTIC TEST SERVICE THAT DETECTS BLOOD CANCER IN PATIENTS.